Suchergebnisse - "Pang, Pengfei"

PubPharm (40)

1

The promotional effect of $ SO_{4} $2− on $ N_{2} $ selectivity for selective catalytic oxidation of ammonia over $ RuO_{2} $/$ ZrO_{2} $ catalyst

enthalten in: Research on chemical intermediates | 2019

von Li, F. | Xia, F. | Zhang, K. | +4

2

The promotional effect of $ SO_{4} $2− on $ N_{2} $ selectivity for selective catalytic oxidation of ammonia over $ RuO_{2} $/$ ZrO_{2} $ catalyst

enthalten in: Research on chemical intermediates | 2019

von Li, F. | Xia, F. | Zhang, K. | +4

3

The promotional effect of $ SO_{4} $2− on $ N_{2} $ selectivity for selective catalytic oxidation of ammonia over $ RuO_{2} $/$ ZrO_{2} $ catalyst

enthalten in: Research on chemical intermediates | 2019

von Li, F. | Xia, F. | Zhang, K. | +4

4

Enzyme-free fluorescent detection of microcystin-LR using hairpin DNA-templated copper nanoclusters as signal indicator

enthalten in: Talanta | 2019

von Zhang, Y. | Zhu, Z. | Teng, X. | +7

5

Angong Niuhuang Pill as adjuvant therapy for treating acute cerebral infarction and intracerebral hemorrhage : A meta-analysis of randomized controlled trials

enthalten in: Journal of ethnopharmacology | 2019

von Liu, H. | Yan, Y. | Pang, P. | +5

6

DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera

enthalten in: Hepatology (Baltimore, Md.) | 2019

von Pang, P. | Hu, X. | Zhou, B. | +14

ErratumIn: Hepatology. 2020 Mar;71(3):1141. - PMID 32200567

7

ZnAsSiO2 nanoparticles as a potential anti-tumor drug for targeting stemness and epithelial-mesenchymal transition in hepatocellular carcinoma via SHP-1/JAK2/STAT3 signaling

enthalten in: Theranostics | 2019

von Huang, Y. | Zhou, B. | Luo, H. | +11

8

DDX24 Mutations Associated With Malformations of Major Vessels to the Viscera

enthalten in: Hepatology | 2019

von Pang, P. | Hu, X. | Zhou, B. | +14

9

A sensitive electrochemical assay for T4 polynucleotide kinase activity based on titanium dioxide nanotubes and a rolling circle amplification strategy

enthalten in: RSC advances | 2018

von Zhang, Y. | Fang, X. | Zhu, Z. | +7

10

Establishment of a CRISPR/Cas9-Mediated Cysltr1 Knockout Mouse Model and iTRAQ-Based Proteomic Analysis

enthalten in: Proteomics. Clinical applications | 2018

von Mao, J. | Hu, X. | Pang, P. | +4